Metastatic melanoma in a 95 years old patient responding to treatment with talimogene laherparepvec followed by nivolumab

Acta Oncol. 2017 Oct;56(10):1327-1330. doi: 10.1080/0284186X.2017.1324212. Epub 2017 May 8.

Authors

Abdul R Naqash¹, Geoffrey Stroud¹, Frances A Collichio², Mahvish Muzaffar¹, Nitika Sharma¹, Paul Walker¹

Affiliations

¹ a Division of Hematology/Oncology , East Carolina University , Greenville , NC , USA.
² b Division of Hematology/Oncology , Lineberger Comprehensive Center, University of North Carolina , NC , USA.

PMID: 28481677
DOI: 10.1080/0284186X.2017.1324212

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Antineoplastic Agents, Immunological / therapeutic use*
Biological Products / therapeutic use*
Biopsy
Female
Herpesvirus 1, Human / genetics
Herpesvirus 1, Human / immunology
Humans
Melanoma / diagnostic imaging
Melanoma / pathology
Melanoma / therapy*
Nivolumab / therapeutic use*
Oncolytic Virotherapy / methods*
Oncolytic Viruses / genetics
Oncolytic Viruses / immunology
Positron-Emission Tomography
Skin / diagnostic imaging
Skin / pathology
Skin Neoplasms / diagnostic imaging
Skin Neoplasms / pathology
Skin Neoplasms / therapy*
Treatment Outcome

Substances

Antineoplastic Agents, Immunological
Biological Products
talimogene laherparepvec
Nivolumab